Medicare Drug Price Negotiation Process – Transparency and Multiple Beneficiaries Engagement

AAHD and the Lakeshore Foundation have joined an Alliance for Aging Research led letter to CMS on the Medicare Drug Price Negotiation Process. We advocate full transparency, utilization management guardrails, prohibiting QALYs (Quality Adjusted Life Years), and Incorporate Multiple Beneficiaries Engagement. Click here for letter.

AAHD is a National Health Council member. Sept 1 NHC CEO blog: Meaningful Patient Engagement Will Be Key To Successful Drug Price Negotiation”:  Meaningful Patient Engagement Will Be Key to Successful Drug Price Negotiation – National Health Council

AAHD works closely with the Partnership To Improve Patient Care: Aug 29 PIPC statement on “Transparency Is A Significant Priority”:PIPC Statement on Selection of Drugs under Medicare Drug Price Negotiation Program Guidance – Partnership to Improve Patient Care (